[1]Claridge,Stephen;Raeppel,Franck;Granger,Marie-Claude;Bernstein,Naomy;Saavedra,Oscar;Zhan,Lijie;Llewellyn,David;Wahhab,Amal;Deziel,Robert;Rahil,Jubrail;Beaulieu,Normand;Nguyen,Hannah;Dupont,Isabelle;Barsalou,Annie;Beaulieu,Carole;Chute,Ian;Gravel,Serge;Robert,Marie-France;Lefebvre,Sylvain;Dubay,Marja;Pascal,Roussen;Gillespie,Jeff;Jin,Zhiyun;Wang,James;Besterman,JeffreyM.;MacLeod,A.Robert;Vaisburg,Arkadii[BioorganicandMedicinalChemistryLetters,2008,vol.18,#9,p.2793-2798]
Title: N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20091201
Title: N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20090301
Title: Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases.
Journal: Bioorganic & medicinal chemistry letters 20080501
Title: Claridge S, et al. Discovery of a novel and potent series of thieno,2-bpyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorg Med Chem Lett. 2008 May 1;18(9):2793-8.
